GLENDALE, N.Y., Jan. 29, 2018 /PRNewswire/ -- New York & Atlantic Railway (NYA)
NYA President James Bonner said, "The detection and remediation of OSA will positively impact employee health and improve employee alertness for safety sensitive jobs." OSA is a sleep disorder that causes fragmented sleep that often results in sleepiness, fatigue, and is associated with potentially serious health issues.
NYA is the first short-line freight railroad in the United States to institute an Obstructive Sleep Apnea screening and treatment program, according to the American Short Line and Regional Railroad Association.
NYA's medical services and safety teams will be working with Rocky Mountain Sleep Disorders Center to institute this OSA program.
"The Brotherhood of Locomotive Engineers & Trainmen – Long Island General Committee of Adjustment, the union that represents NYA's engineers and conductors, has been supportive and helpful as NYA implements this valuable program," Bonner added.
About New York & Atlantic Railway
New York & Atlantic Railway (www.anacostia.com/railroads/nya) began freight train operation in May 1997 on 270 route miles of track owned by the Long Island Rail Road. NYA serves a diverse customer base and shares track with the densest passenger system in the United States. NYA connects with Canadian Pacific, CSX, New York New Jersey Rail, Norfolk Southern, Brookhaven Rail Terminal, and Providence and Worcester railroads.
About Anacostia Rail Holdings
Anacostia Rail Holdings Company is a short-line holding company operating six railroads in seven states. In addition to the New York & Atlantic Railway, Anacostia's other lines include Chicago South Shore & South Bend Railroad, Gulf Coast Switching Company, Louisville & Indiana Railroad Company, New York & Atlantic Railway Company, Northern Lines Railway, and Pacific Harbor Line.
View original content:http://www.prnewswire.com/news-releases/new-york--atlantic-railway-starts-sleep-apnea-program-300589286.html
SOURCE New York & Atlantic Railway
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All